Under the terms of the partnership, UT Health Northeast’s cancer program will clinically and operationally integrate with MD Anderson. The cancer program will also be rebranded as the UT Health Northeast MD Anderson Cancer Center once the partnership begins in 2017.
The organizations will jointly recruit all future program physicians and medical staff. Officials said a search is underway to hire a medical director to lead the program.
UT Health Northeast joins six other healthcare institutions across the U.S. and three facilities in Brazil, Spain and Turkey in its new partnership with MD Anderson.
“This partnership will help cancer care in our region to take a quantum leap forward, which is needed[,] as the lack of access to care is a key reason why citizens from our region are the unhealthiest in our state,” said UT Health Northeast President Kirk Calhoun, MD. “Tackling this regional healthcare crisis with the top-ranked cancer center in the world with the common goals of reducing cancer rates, improving outcomes, and making a measurable impact on the health and wellbeing of our family, friends, and neighbors is not only vital, but both humbling and hugely inspiring.”
More articles on transactions and valuations:
Summit Healthcare Regional Medical Center to join Mayo Clinic Care Network
Anesthesiology Consultants, US Anesthesia Partners team up
True Health Diagnostics launches laboratory management service for hospital systems
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
